4.8 Article

Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription

期刊

NATURE
卷 454, 期 7200, 页码 126-U11

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature06992

关键词

-

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [P30 CA008748, R01 CA052599-19, CA52599, CA097134, P30 CA08748, R01 CA052599] Funding Source: Medline
  3. NHLBI NIH HHS [HL59694, R01 HL059694-10, R01 HL059694] Funding Source: Medline
  4. NIDDK NIH HHS [DK39949, R37 DK039949, R37 DK039949-26, DK074868, R01 DK091183, R01 DK039949] Funding Source: Medline
  5. NINDS NIH HHS [R01 NS034934, R01 NS034934-20A1, NS34934] Funding Source: Medline

向作者/读者索取更多资源

With the recent recognition of non- coding RNAs ( ncRNAs) flanking many genes(1-5), a central issue is to obtain a full understanding of their potential roles in regulated gene transcription programmes, possibly through different mechanisms(6-12). Here we show that an RNA- binding protein, TLS ( for translocated in liposarcoma), serves as a key transcriptional regulatory sensor of DNA damage signals that, on the basis of its allosteric modulation by RNA, specifically binds to and inhibits CREB- binding protein ( CBP) and p300 histone acetyltransferase activities on a repressed gene target, cyclin D1 ( CCND1) in human cell lines. Recruitment of TLS to the CCND1 promoter to cause gene- specific repression is directed by single- stranded, low- copy- number ncRNA transcripts tethered to the 5' regulatory regions of CCND1 that are induced in response to DNA damage signals. Our data suggest that signal-induced ncRNAs localized to regulatory regions of transcription units can act cooperatively as selective ligands, recruiting and modulating the activities of distinct classes of RNA- binding co-regulators in response to specific signals, providing an unexpected ncRNA/RNA-binding protein-based strategy to integrate transcriptional programmes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据